University of Pennsylvania

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1740-11-14

Employees: 5K

Market Cap: -

Website: http://www.upenn.edu

Clinical Trials

Trial of Topical Cidofovir for the Prevention of Hair Growth

Phase 2

Completed

Conditions: Prevention of Hair Growth

Interventions: Drug: 1% topical cidofovir
Drug: 3% topical cidofovir
Drug: Placebo

First Posted Date: 2009-07-29

Last Posted Date: 2012-03-19

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 20

Registration Number: NCT00948506

Locations: 🇺🇸
Hospital of the University of PA, Philadelphia, Pennsylvania, United States

Research Study on the Effects of Smoking on Arteries

Completed

Conditions: Smoking

First Posted Date: 2009-07-29

Last Posted Date: 2009-10-27

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 105

Registration Number: NCT00948454

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

Effects of Chantix on Relapse Prevention for Smoking Cessation

Phase 4

Completed

Conditions: Nicotine Dependence

Interventions: Drug: Varenicline
Drug: Placebo

First Posted Date: 2009-07-29

Last Posted Date: 2010-08-17

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 62

Registration Number: NCT00948649

Locations: 🇺🇸
Tobacco Use Research Center, University of Pennsylvania, Philadelphia, Pennsylvania, United States

Support for Cardiovascular Health in African American Primary Care Patients

Not Applicable

Completed

Conditions: Blood Pressure
Cardiovascular Diseases

Interventions: Behavioral: Peer Coach Phone Calls
Behavioral: Health Educator Visits
Other: written materials

First Posted Date: 2009-07-29

Last Posted Date: 2017-07-21

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 130

Registration Number: NCT00948714

Locations: 🇺🇸
PennCare Internal Medicine Associates, Philadelphia, Pennsylvania, United States
🇺🇸
Edward S. Cooper Practice of General Internal Medicine, Philadelphia, Pennsylvania, United States

Treatment of Smoking Among Individuals With PTSD

Phase 2

Completed

Conditions: Cigarette Smoking
Nicotine Dependence
Post-traumatic Stress Disorder
Tobacco Use Disorder

Interventions: Drug: Varenicline
Behavioral: Medication Management Counseling
Behavioral: Prolonged Exposure

First Posted Date: 2009-07-10

Last Posted Date: 2017-11-14

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 142

Registration Number: NCT00937235

Locations: 🇺🇸
University of Pennsylvania School of Medicine, Dept of Psychiatry, Center for Treatment and Study of Anxiety, Philadelphia, Pennsylvania, United States

Effect of Pasireotide Long Acting Release (LAR) on Gonadotroph Adenomas

Phase 2

Terminated

Conditions: Gonadotroph Adenomas

Interventions: Drug: pasireotide LAR

First Posted Date: 2009-06-29

Last Posted Date: 2017-11-28

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 2

Registration Number: NCT00929669

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

Examining Behavior Therapy for Trichotillomania in Children and Adolescents

Not Applicable

Completed

Conditions: Trichotillomania

Interventions: Behavioral: Behavior Therapy
Behavioral: Supportive Counseling

First Posted Date: 2009-06-10

Last Posted Date: 2017-08-01

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 61

Registration Number: NCT00917098

Locations: 🇺🇸
Child and Adolescent OCD, Tic, Trichotillomania, and Anxiety Group (COTTAGe), Philadelphia, Pennsylvania, United States

Advancing Niacin by Inhibiting Flushing (ANTI-FLUSH)

Phase 4

Completed

Conditions: Flushing

Interventions: Dietary Supplement: Quercetin
Dietary Supplement: Placebo

First Posted Date: 2009-06-03

Last Posted Date: 2015-03-05

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 17

Registration Number: NCT00913081

Locations: 🇺🇸
CTRC Univ. of Penn - Andrew Mutch Bldg., 4th floor, Phila, Pennsylvania, United States
🇺🇸
University of Pennsylvania, Phila, Pennsylvania, United States

The Vascular Biology of Dipyridamole in Peripheral Arterial Disease (PAD)

Not Applicable

Terminated

Conditions: Peripheral Arterial Disease

Interventions: Drug: Aspirin 25 mg bid
Drug: Dipyridamole 200 mg bid

First Posted Date: 2009-05-21

Last Posted Date: 2017-09-05

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 25

Registration Number: NCT00906035

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States
🇺🇸
Presbyterian Hospital, 51 N. 39th St., Philadelphia, Pennsylvania, United States
🇺🇸
Translational Research Ctr.,3400 Civic Center Blvd, Building 421, 10th floor, Room 421, Philadelphia, Pennsylvania, United States

Predictors of Anticoagulation Control on Warfarin Therapy

Completed

Conditions: Heart Valve Replacement
Atrial Fibrillation
Deep Vein Thrombosis

First Posted Date: 2009-05-20

Last Posted Date: 2016-05-20

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 687

Registration Number: NCT00905177

Locations: 🇺🇸
Hospital of the University of Pennsylvania, Anticoagulation Management Center, Philadelphia, Pennsylvania, United States
🇺🇸
Philadelphia Veteran Affairs Medical Center, Philadelphia, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy